Miocardiopatía no compactada como causa de insuficiencia cardíaca en Lupus Eritematoso Sistémico
Resumen
La Miocardiopatía no compactada (MCNC) representa una anomalía de la morfología miocárdica frecuentemente asociada a una etiología genética, sin embargo, hay escasas descripciones de su asociación con enfermedades autoinmunes. Se presenta revisión de la literatura y el caso de una paciente lúpica que ingresa con signos de insuficiencia cardiaca descompensada con confirmación de VINC por ecocardiograma y resonancia magnética nuclear cardiaca (RMN-C).Citas
I. Lozano David Serrano, Vílchez Francisco González. Miocardiopatía no compactada. Rev.Urug.Cardiol. [Internet]. 2019 Abr [citado 2021 Jun 14] ; 34( 1 ): 284-306. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-04202019000100284&lng=es. http://dx.doi.org/10.29277/cardio.34.1.20.
II. Freedom RM, Yoo SJ, Perrin D, Taylor G, Petersen S, Anderson RH. The morphological spectrum of ventricular noncompaction. Cardiol Young. 2005; 15(4):345-64.10.1017/S1047951105000752 [Links].
III. Oechslin E, Jenni R. Left ventricular noncompaction revisited: a distinct phenotype with genetic heterogeneity? Eur Heart J. 2011; 32(12):1446-56. doi:10.1093/eurheartj/ehq508 [Links].
IV. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113(14):1807-16. doi: 10.1161/CIRCULATIONAHA.106.174287 [Links].
V. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93(5):841-2. doi: 10.1161/01. CIR.93.5.841 [Links].
VI. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2008; 29(2):270-6. doi: 10.1093/eurheartj/ehm342 [Links]
VII. Weir-McCall JR, Yeap PM, Papagiorcopulo C, Fitzgerald K, Gandy SJ, Lambert M, Belch JJ, et al. Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomiopathy? J Am Coll Cardiol. 2016; 68(20):2157-65. doi: 10.1016/j.jacc. 2016.08.054 [Links].
VIII. Frischknecht BS, Attenhofer Jost CH, Oechslin EN, Seifert B, Hoigne P, Roos M, et al. Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. J Am Soc Echocardiogr. 2005; 18(8):865-72. doi: 10.1016/j.echo.2005.03.011 [Links].
IX. Dobranici M, Tocitu A, Delcea C, Dan GA. Left Ventricular noncompaction in a patient with systemic lupus erythematosus. Rom J Intern Med. 2019 Mar 1;57(1):78-82. doi: 10.2478/rjim-2018-0032. PMID: 30379642.
X. RABELO CF, BATISTELLA F, GODINHO RN, MACHADO TS, VELHO FJP, STAUB HL. Systemic lupus erythematosus and transient left ventricular noncompaction. Acta Reumatol Port 2014;39:274-6.
XI. OZKOK A, ACAR G, ELCIOGLU OC, BAKAN A, ATILGAN KG, SASAK G, et al. Cardiomyopathy mimicking left ventricular noncompaction in a patient with lupus nephritis. CEN Case Reports 2012;1:69-72.
XII. ASHRAFI R, GARG P, MCKAY E, GOSNEY J, CHUAH S, DAVIS G. Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review. Cardiol Res Pract 2011;2011:578390.
XIII. Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH. Developmental patterning of the myocardium. Anat Rec. 2000; 258(4):319-37. doi: 10.1002/(SICI)1097-0185(20000401)258:4<319:AID-AR1>3.0.CO;2-O [Links].
XIV. Da Rosa LV, Salemi VM, Alexandre LM, Mady C. Noncompaction cardiomyopathy: a current view. Arq Bras Cardiol. 2011 Jul;97(1):e13-9. English, Portuguese, Spanish. doi: 10.1590/s0066-782x2011000900021. PMID: 21894393.
XV. Attenhofer Jost CH, Connolly HM, O’Leary PW, Warnes CA, Tajik AJ, Seward JB. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc. 2005; 80(3):361–8. doi: 10.4065/80.3.361.
XVI. Towbin JA, Bowles NE. The failing heart. Nature 2002; 415(6868):227-33. doi: 10.1038/415227ª.
XVII. Stollberger C, Finsterer J, Blazek G. Isolated left ventricular abnormal trabeculation is a cardiac manifestation of neuromuscular disorders. Cardiology 2000; 94(1):72-6. doi: 10.1159/000007050
XVIII. Gati S, Chandra N, Bennett RL, Reed M, Kervio G, Panoulas VF, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart 2013; 99(6):401–8. doi:10.1136/heartjnl-2012-303418
XIX. Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr. 2004; 17(1):91-100. doi: 10.1016/S0894- 7317(03)00514-5
XX. Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. Lancet. 2015 Aug 22;386(9995):813-25. doi: 10.1016/S0140-6736(14)61282-4. Epub 2015 Apr 9. PMID: 25865865.
Derechos de autor 2021 A nombre de los autores. Derechos de reproducción: Sociedad Argentina de Reumatología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.